Chelation therapy, non-overload conditions
Record ID 32005000018
English
Authors' objectives:
Chelation therapy utilizes compounds that bind with heavy metal ions to reduce the accumulation and enhance the urinary and fecal excretion of these metals. Chelation therapy has been used to treat heavy metal overload, such as iron overload and lead poisoning, but has also been investigated as a treatment for a variety of non-overload conditions, such as atherosclerosis, anthracycline-associated heart damage, Alzheimer's disease, and rheumatoid arthritis.
Authors' methods:
Review
Details
Project Status:
Completed
Year Published:
2004
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=1868
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Alzheimer Disease
- Arteriosclerosis
- Arthritis, Rheumatoid
- Chelation Therapy
- Heart Diseases
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.